122 related articles for article (PubMed ID: 15065884)
1. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
Li J; Melvin WS; Tsai MD; Muscarella P
Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
[TBL] [Abstract][Full Text] [Related]
2. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
Li J; Li H; Tsai MD
Biochemistry; 2003 Jun; 42(22):6921-8. PubMed ID: 12779347
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
Fåhraeus R; Laín S; Ball KL; Lane DP
Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
6. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
Noh SJ; Li Y; Xiong Y; Guan KL
Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).
Sugimoto M; Nakamura T; Ohtani N; Hampson L; Hampson IN; Shimamoto A; Furuichi Y; Okumura K; Niwa S; Taya Y; Hara E
Genes Dev; 1999 Nov; 13(22):3027-33. PubMed ID: 10580009
[TBL] [Abstract][Full Text] [Related]
8. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity.
Reynaud EG; Guillier M; Leibovitch MP; Leibovitch SA
Oncogene; 2000 Feb; 19(9):1147-52. PubMed ID: 10713702
[TBL] [Abstract][Full Text] [Related]
9. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
Suzuki T; Kitao S; Matsushime H; Yoshida M
EMBO J; 1996 Apr; 15(7):1607-14. PubMed ID: 8612584
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
Suzuki T; Narita T; Uchida-Toita M; Yoshida M
Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
Sung YH; Shin J; Shin J; Lee W
J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
[TBL] [Abstract][Full Text] [Related]
16. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
Li J; Joo SH; Tsai MD
Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
[TBL] [Abstract][Full Text] [Related]
17. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.
Hong SW; Kim CJ; Park WS; Shin JS; Lee SD; Ko SG; Jung SI; Park IC; An SK; Lee WK; Lee WJ; Jin DH; Lee MS
Cancer Res; 2009 Feb; 69(3):741-6. PubMed ID: 19176394
[TBL] [Abstract][Full Text] [Related]
18. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
19. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
